Burke Robert David 13D/13G Filings for Nascent Biotech, Inc. (NBIO)

Burke Robert David 13D and 13G filings for Nascent Biotech, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-04-14
1:51 pm
Purchase
2023-04-1413DNASCENT BIOTECH INC.
NBIO
Burke Robert David21,272,889
16.700%
21,272,889increase
(New Position)
Filing